U.S. markets closed

Amphastar Pharmaceuticals, Inc. (AMPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.060.00 (0.00%)
At close: 04:00PM EDT
32.00 -0.06 (-0.19%)
After hours: 07:35PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Bollinger Bands

Bollinger Bands

Previous Close32.06
Bid31.82 x 1300
Ask32.85 x 3200
Day's Range31.94 - 33.15
52 Week Range17.56 - 44.46
Avg. Volume550,508
Market Cap1.565B
Beta (5Y Monthly)N/A
PE Ratio (TTM)19.43
EPS (TTM)1.65
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est41.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
1% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for AMPH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Amphastar Pharmaceuticals, Inc.
    AMPH: Raising target price to $37.00AMPHASTAR PHARMACEUTICALS IN has an Investment Rating of BUY; a target price of $37.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.
    Fair Value
    Economic Moat
    last monthArgus Research
View more